Search results
ImmunoGen (IMGN) Q1 Earnings Beat, Elahere Uptake Encouraging
Zacks via Yahoo Finance· 1 year agoImmunoGen (IMGN) reports impressive Q1 earnings results on strong adoption of sole-marketed drug...
News Flash: Analysts Just Made An Incredible Upgrade To Their ImmunoGen, Inc. (NASDAQ:IMGN)...
Simply Wall St. via Yahoo Finance· 1 year agoCelebrations may be in order for ImmunoGen, Inc. (NASDAQ:IMGN) shareholders, with the analysts...
Biotech Leader ImmunoGen Eyes Early Buy Point Amid Path To Profitability
Investor's Business Daily· 7 months agoBiotech leader ImmunoGen, Monday's pick for IBD 50 Growth Stocks To Watch, is approaching an early...
ImmunoGen, Day One Surge On Cancer Drug Updates, But Arcus Dips
Investor's Business Daily· 1 year agoImmunoGen and Day One Biopharmaceuticals unveiled promising cancer treatment updates over the...
Good News for Patients Is Lifting These 2 Biopharma Stocks
Motley Fool· 1 year agoOverall, the stock market is facing a serious case of the jitters on Wednesday morning, as investors...
AbbVie joins ADC dealmaking with $10B ImmunoGen buyout
BioPharma Dive via Yahoo Finance· 7 months agoAbbVie is expanding its investment in targeted cancer medicines, announcing Thursday a $10.1 billion...
Zacks.com featured highlights include Confluent, Pinterest, ICON and ImmunoGen
Zacks via Yahoo Finance· 8 months agoFor Immediate Release Chicago, IL – November 8, 2023 – Stocks in this week’s article are Confluent...
CRISPR Therapeutics Stock Earns 88 RS Rating On U.K. Regulator News
Investor's Business Daily· 7 months agoWhen looking for the best stocks to buy and watch, focus on those with rising relative price...
Biotech Stock Roundup: HZNP Surges on AMGN Offer, TRDA Gains on VRTX Deal & More
Zacks via Yahoo Finance· 2 years agoThe biotech sector was in the spotlight this week courtesy of acquisition news and strategic...
AbbVie Stock (NYSE:ABBV): Bet on a Smart Drugmaker and Dealmaker
TipRanks via Yahoo Finance· 7 months agoIs AbbVie (NYSE:ABBV) a drugmaker to wager on now? I believe it’s a very smart move to consider...